|
Quarterly Activities Report
|
4 May 2023 at 7:15pm
|
|
Appendix 4C - March 2023
|
28 April 2023 at 9:40am
|
|
Growth momentum maintained
|
28 April 2023 at 9:40am
|
|
Change of Director's Interest Notice
|
1 March 2023 at 12:35pm
|
|
Investor Presentation
|
22 February 2023 at 7:10pm
|
|
Revenue growth momentum continues in 1H FY23
|
22 February 2023 at 7:05pm
|
|
Half Yearly Report and Accounts
|
22 February 2023 at 7:05pm
|
|
Updated Quarterly Activities
|
1 February 2023 at 7:10pm
|
|
Appendix 4C - December 2022
|
30 January 2023 at 9:30am
|
|
Second quarter revenue growth of 17% to $21.4 million
|
30 January 2023 at 9:30am
|
|
Results of Meeting
|
25 November 2022 at 2:00pm
|
|
AGM Chairman and CEO addresses
|
25 November 2022 at 9:35am
|
|
AGM Investor Presentation
|
25 November 2022 at 9:30am
|
|
Change of Registry Address
|
31 October 2022 at 4:30pm
|
|
Appendix 4C....typographical correction
|
26 October 2022 at 7:15pm
|
|
AGM Proxy
|
25 October 2022 at 6:15pm
|
|
Notice of AGM
|
25 October 2022 at 6:15pm
|
|
Appendix 4C Cash Flow Report
|
25 October 2022 at 9:20am
|
|
North America Q1 revenue growth leads the way
|
25 October 2022 at 9:20am
|
|
Change in substantial holding
|
4 October 2022 at 3:35pm
|
|
Change of Director's Interest Notice
|
30 September 2022 at 5:35pm
|
|
Corporate Governance Statement
|
27 September 2022 at 10:25am
|
|
Appendix 4G
|
27 September 2022 at 10:25am
|
|
Annual Report to shareholders
|
27 September 2022 at 10:25am
|
|
Investor presentation
|
23 August 2022 at 9:45am
|
|
FY22 results and FY23 guidance
|
23 August 2022 at 9:45am
|
|
Preliminary Final Report
|
23 August 2022 at 9:35am
|
|
FY22 Full year financial results investor conference call
|
8 August 2022 at 3:10pm
|
|
Quarterly Cash Flow Report
|
26 July 2022 at 9:40am
|
|
Record Q4 and delivers on FY22 revenue guidance
|
26 July 2022 at 9:40am
|
|
Change in substantial holding from AEF
|
31 May 2022 at 12:15pm
|
|
Quarterly Appendix 4C Cash Flow Report
|
27 April 2022 at 9:50am
|
|
Strong revenue growth and continued positive momentum
|
27 April 2022 at 9:40am
|
|
Change of Director's Interest Notice
|
18 March 2022 at 6:20pm
|
|
SomnoMed introduces Rest Assure
|
22 February 2022 at 10:05am
|
|
Investor Presentation
|
22 February 2022 at 10:05am
|
|
Revenues on track despite COVID-19 disruptions
|
22 February 2022 at 10:05am
|
|
Half Yearly Report and Accounts
|
22 February 2022 at 10:05am
|
|
Half-year financial results Investor conference call details
|
14 February 2022 at 9:45am
|
|
World first technology enabled oral appliance
|
31 January 2022 at 10:10am
|
|
Appendix 4C Cash Flow Report
|
27 January 2022 at 10:10am
|
|
North America Q2 revenue 36% amid regional variability
|
27 January 2022 at 10:05am
|
|
Notification regarding unquoted securities - SOM
|
10 December 2021 at 6:20pm
|
|
Change of Director's Interest Notice
|
1 December 2021 at 6:50pm
|
|
AGM results
|
25 November 2021 at 4:35pm
|
|
AGM Presentation
|
25 November 2021 at 10:25am
|
|
JobKeeper Payments Notice
|
9 November 2021 at 6:45pm
|
|
Notification regarding unquoted securities - SOM
|
4 November 2021 at 6:15pm
|
|
Proxy Form AGM
|
28 October 2021 at 5:15pm
|
|
Letter to shareholders re AGM
|
28 October 2021 at 5:05pm
|
SomnoMed